1. Home
  2. IPO
  • Star Imaging And Path Lab Ltd IPO
midistep

Star Imaging and Path Lab IPO

  • Status: Closed
  • RHP:
  • ₹ 270,000 / 2000 shares

    Minimum Investment

Star Imaging and Path Lab IPO Details

  • Open Date

    08 Aug 2025

  • Close Date

    12 Aug 2025

  • Listing Date

    18 Aug 2025

  • IPO Price Range

    ₹ 135 to ₹142

  • IPO Size

    ₹ 62.65 Cr

  • Listing Exchange

    BSE SME

Open Free Demat Account

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Financials SWOT FAQ Contacts

Star Imaging and Path Lab IPO Timeline

Star Imaging and Path Lab IPO Subscription Status

Last Updated: 12 August 2025 6:28 PM by 5paisa

Star Imaging & Path Lab Limited, a diagnostic healthcare provider, is launching a ₹62.65 crore IPO. The company offers radiology services like X-rays, ultrasounds, CT scans, MRIs, and pathology tests including haematology, microbiology, PCR, and histopathology. With a strong regional presence, advanced diagnostic technology, and 209 full-time employees as of 30 September 2024, it serves individuals and healthcare institutions, delivering accurate, timely reports for effective diagnosis and treatment.

Established in: 2004
Managing Director: Mr. Pawan Gupta

 

Peers

1. Chandan Healthcare Ltd.
2. Vijaya Diagnostic Centre Ltd.
3. Metropolis Healthcare Ltd.
 

Star Imaging and Path Lab Objectives

1. The company intends to utilise a portion of the IPO proceeds to meet its working capital requirements.
2. A part of the funds will be used to repay or prepay certain borrowings previously availed by the company.
3. The proceeds will also be directed towards funding capital expenditure for the purchase of refurbished medical equipment for its existing facilities.
4. Additionally, the funds will be used for general corporate purposes.
 

Star Imaging and Path Lab IPO Size

Types Size
Total IPO Size ₹62.65 Cr.
Offer For Sale ₹13.80 Cr
Fresh Issue ₹48.85 Cr.

 

Star Imaging and Path Lab IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 2,000 270,000
Retail (Max) 2 2,000 270,000
S-HNI (Min) 3 3000 405,000
S-HNI (Max) 7 7000 945,000
B-HNI (Min) 8 8000 10,80,000

Star Imaging and Path Lab IPO Reservation

Investors Category Subscription (times) Shares Offered Shares bid for Total Amount (Cr.)*
QIB 12.85 8,71,000 1,11,88,000 158.870
NII (HNI) 4.38 6,57,000 28,75,000 40.825
Retail 2.30 15,28,000 35,16,000 49.927
Total** 5.66 31,08,000 1,75,95,000 249.849

 

*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY24 FY25
Revenue 58.53 78.78 83.50
EBITDA 5.81 22.34 28.57
PAT 0.58 12.45 15.96
Particulars (in Rs. Crores) FY23 FY24 FY25
Total Assets 61.23 81.64 98.16
Share Capital 1.50 1.50 13.18
13.50 26.56 30.64 32.73
Particulars (in Rs. Crores) FY23 FY24 FY25
Net Cash Generated From / (used in) operating activities 5.27 18.34 -6.03
Net Cash Generated From / (used in) investing activities -7.22 -6.87 -3.97
Net Cash Generated From / (used in) financing activities -4.74 1.89 -0.37
Net Increase (Decrease) In Cash And Cash Equivalents -6.69 13.36 -10.37


Strengths

1. Advanced MRI, CT, and lab tools enable accurate and timely diagnostic results.
2. Expert staff in radiology and pathology ensures precise interpretation of test outcomes.
3. Standardised procedures ensure reliable sample collection and prevent contamination.
4. High diagnostic accuracy enhances patient trust and operational credibility.

Weaknesses

1. Heavy reliance on advanced equipment increases risk during technical failures.
2. Lack of emergency services limits immediate care for critical patients.
3. Peak-time overloads may cause delays in reports and appointments.
4. High equipment cost burden may affect scalability and maintenance.

Opportunities

1. Expanding into rural areas can address unmet diagnostic healthcare needs.
2. AI and automation can improve efficiency and reduce diagnostic turnaround time.
3. Clinical research tie-ups can boost innovation and diversify revenue streams.
4. Rising demand for preventive care opens doors for regular diagnostic services.
 

Threats

1. Rapid tech evolution may render current equipment obsolete quickly.
2. Regulatory shifts can disrupt operations or increase compliance costs.
3. Seasonal fluctuations may result in inconsistent demand and revenues.
4. Intense competition may lead to pricing pressure and reduced margins.
 

1. Operates in a high-growth diagnostics sector with rising demand and low organised penetration.
2. Strong focus on accurate testing, specialised staff, and advanced diagnostic infrastructure.
3. Proceeds to strengthen working capital, repay debt, and upgrade medical equipment.
4. Backed by a clear business model and expansion strategy in a growing healthcare segment.
 

1. Rising chronic diseases, aging population and healthcare awareness are driving demand.
2. Highly fragmented market; top four national chains together account for ~6 % of the overall market. 
3. Digital and AI-enabled imaging innovation boosting efficiency and reach. 
4. Government support via schemes like PLI, Ayushman Bharat and PPP models.
 

Upcoming IPOs

View all IPOs
  • Companies
  • Type
  • Opening On

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

Star Imaging & Path Lab IPO opens from August 8, 2025 to August 12, 2025.
 

The size of Star Imaging & Path Lab IPO is ₹62.65 Cr.

The price band of Star Imaging & Path Lab IPO is ₹135 to ₹142 per share.

To apply for Star Imaging & Path Lab IPO, follow the steps given below:

  • Login to your 5paisa account and select the issue in the current IPO section.    
  • Enter the number of lots and the price at which you wish to apply for the Star Imaging & Path Lab IPO. 
  • Enter your UPI ID and click on submit. You will receive a mandate notification to block funds in your UPI app.
  • On approving the mandate, your bid will be placed with the exchange.    
     

The minimum lot size of Star Imaging & Path Lab IPO is 2 lots of 2000 shares and the investment required is ₹270,000.

The share allotment date of Star Imaging & Path Lab IPO is August 13, 2025

The Star Imaging & Path Lab IPO will likely be listed on August 18, 2025.

Share India Capital Services Pvt Ltd is the book running lead manager for Star Imaging & Path Lab IPO.

  • The company intends to utilise a portion of the IPO proceeds to meet its working capital requirements.
  • A part of the funds will be used to repay or prepay certain borrowings previously availed by the company.
  • The proceeds will also be directed towards funding capital expenditure for the purchase of refurbished medical equipment for its existing facilities.
  • Additionally, the funds will be used for general corporate purposes.